{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:37:04Z","timestamp":1791999424735,"version":"4.4.0"},"publisher-location":"Chichester, UK","reference-count":71,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002915","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:38:44Z","timestamp":1069385924000},"source":"Crossref","is-referenced-by-count":27,"title":["Oral sumatriptan for acute migraine"],"prefix":"10.1002","author":[{"given":"Douglas C","family":"McCrory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca N","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7,21]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD002915-BIB1|cit1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000116818","article-title":"A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine","volume":"32","year":"1992","journal-title":"European Neurology"},{"issue":"5","key":"10.1002\/14651858.CD002915-BIB2|cit2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s100720070064","article-title":"Efficacy and tolerability of sumatriptan in the treatment of multiple migraine attacks","volume":"21","author":"Bussone","year":"2000","journal-title":"Neurological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD002915-BIB3|cit3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000116759","article-title":"A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine","volume":"31","year":"1991","journal-title":"European Neurology"},{"issue":"8 Suppl 7","key":"10.1002\/14651858.CD002915-BIB4|cit4","first-page":"S5","article-title":"Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths","volume":"45","author":"Cutler","year":"1995","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD002915-BIB5|cit5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1468-2982.1999.019004232.x","article-title":"Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo","volume":"19","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD002915-BIB6|cit6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0333102489009S10187","article-title":"Oral GR43175, a 5HT1-like agonist, for treatment of the acute migraine attack: an international study - preliminary results","volume":"9 Suppl 10","author":"Dahl\u00f6f","year":"1989","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD002915-BIB7|cit7","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1007\/BF01642909","article-title":"Clinical experience with oral sumatriptan: a placebo-controlled, dose-ranging study","volume":"238 Suppl 1","author":"Patten","year":"1991","journal-title":"Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD002915-BIB8|cit8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000116632","article-title":"Sumatriptan - an oral dose-defining study","volume":"31","year":"1991","journal-title":"European Neurology"},{"issue":"5","key":"10.1002\/14651858.CD002915-BIB9|cit9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1468-2982.1994.1405330.x","article-title":"Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences","volume":"14","author":"Ferrari","year":"1994","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD002915-BIB10|cit10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1526-4610.2001.111006391.x","article-title":"Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine","volume":"41","author":"Freitag","year":"2001","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD002915-BIB11|cit11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1468-2982.2000.00004.x","article-title":"Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design","volume":"20","author":"Geraud","year":"2000","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD002915-BIB12|cit12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1212\/WNL.54.1.156","article-title":"Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan","volume":"54","author":"Goadsby","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002915-BIB13|cit13","first-page":"368","article-title":"A comparison of oral eletriptan (UK-116,044) (20-80 mg) and oral sumatriptan (100 mg) in the acute treatment of migraine [Abstract]","volume":"16","author":"Jackson","year":"1996","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1002\/14651858.CD002915-BIB14|cit14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1526-4610.1998.3810737.x","article-title":"Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine","volume":"38","author":"Goldstein","year":"1998","journal-title":"Headache"},{"issue":"8","key":"10.1002\/14651858.CD002915-BIB15|cit15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0149-2918(00)80069-7","article-title":"Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients","volume":"22","author":"G\u00f6bel","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD002915-BIB16|cit16","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0149-2918(00)80068-5","article-title":"Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study","volume":"22","author":"Havanka","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD002915-BIB17|cit17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000116758","article-title":"Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine","volume":"31","year":"1991","journal-title":"European Neurology"},{"issue":"3","key":"10.1002\/14651858.CD002915-BIB18|cit18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1526-4610.1998.3803201.x","article-title":"Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study","volume":"38","author":"Myllyl\u00e4","year":"1998","journal-title":"Headache"},{"issue":"11","key":"10.1002\/14651858.CD002915-BIB19|cit19","first-page":"721","article-title":"Evaluation of the efficacy of oral sumatriptan in the management of migraine attacks. Clinical results","volume":"146","author":"Centonze","year":"1995","journal-title":"Clinica Terapeutica"},{"issue":"3","key":"10.1002\/14651858.CD002915-BIB20|cit20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF00868340","article-title":"Oral sumatriptan compared with placebo in the acute treatment of migraine","volume":"241","author":"Nappi","year":"1994","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD002915-BIB21|cit21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1526-4610.1998.3803184.x","article-title":"Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan","volume":"38","author":"Pfaffenrath","year":"1998","journal-title":"Headache"},{"issue":"2","key":"10.1002\/14651858.CD002915-BIB22|cit22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/030006059502300202","article-title":"High efficacy and low frequency of headache recurrence after oral sumatriptan","volume":"23","author":"Pini","year":"1995","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD002915-BIB23|cit23","first-page":"16","article-title":"Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study","volume":"105","author":"Salonen","year":"1999","journal-title":"International Journal of Clinical Practice Supplement"},{"issue":"8 Suppl 7","key":"10.1002\/14651858.CD002915-BIB24|cit24","first-page":"S10","article-title":"Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study","volume":"45","author":"Sargent","year":"1995","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002915-BIB25|cit25","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1016\/S0022-510X(97)86047-9","article-title":"Efficacy and tolerability of sumatriptan tablets 50 mg in patients naive to sumatriptan [Abstract]","volume":"150 Suppl 1","author":"Fazekas","year":"1997","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD002915-BIB26|cit26","first-page":"7","article-title":"A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine","volume":"105","author":"Savani","year":"1999","journal-title":"International Journal of Clinical Practice Supplement"},{"issue":"8","key":"10.1002\/14651858.CD002915-BIB27|cit27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/qjmed\/89.8.613","article-title":"Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice","volume":"89","author":"Scott","year":"1996","journal-title":"QJM"},{"issue":"1","key":"10.1002\/14651858.CD002915-BIB28|cit28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0149-2918(01)80036-9","article-title":"Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan","volume":"23","author":"Colman","year":"2001","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD002915-BIB29|cit29","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archneur.58.6.944","article-title":"Oral almotriptan vs oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison","volume":"58","author":"Spierings","year":"2001","journal-title":"Archives of Neurology"},{"issue":"45","key":"10.1002\/14651858.CD002915-BIB30|cit30","first-page":"6435","article-title":"The combination of oral lysine-acetylsalicylate and metoclopramide compared with oral sumatriptan in the treatment of migraine attacks. A randomized, double-blind, placebo-controlled clinical trial","volume":"158","author":"Tfelt-Hansen","year":"1996","journal-title":"Ugeskrift for Laeger"},{"issue":"8980","key":"10.1002\/14651858.CD002915-BIB31|cit31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(95)91554-0","article-title":"The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine","volume":"346","author":"Tfelt-Hansen","year":"1995","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD002915-BIB32|cit32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1526-4610.1998.3810748.x","article-title":"Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine","volume":"38","author":"Tfelt-Hansen","year":"1998","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD002915-BIB33|cit33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1468-2982.1992.1201039.x","article-title":"Sumatriptan in the treatment of acute migraine with aura","volume":"12","author":"Banerjee","year":"1992","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD002915-BIB34|cit34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/0333102491011S11122","article-title":"The acute treatment of migraine with aura with sumatriptan [Abstract]","volume":"11 Suppl 11","author":"Findley","year":"1991","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD002915-BIB35|cit35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archfami.3.9.766","article-title":"Oral sumatriptan in the treatment of recurrent headache","volume":"3","author":"Cady","year":"1994","journal-title":"Archives of Family Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002915-BIB36|cit36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1468-2982.1997.1705591.x","article-title":"Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study","volume":"17","author":"Carpay","year":"1997","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD002915-BIB37|cit37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1468-2982.1997.1701031.x","article-title":"A within-patient comparison of subcutaneous and oral sumatriptan in the acute treatment of migraine in general practice","volume":"17","author":"Gruffydd-Jones","year":"1997","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD002915-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1212\/WNL.48.4.1100","article-title":"Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults?","volume":"48","author":"Hamalainen","year":"1997","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD002915-BIB39|cit39","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1526-4610.2001.01138.x","article-title":"Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine","volume":"41","author":"Loder","year":"2001","journal-title":"Headache"},{"issue":"4","key":"10.1002\/14651858.CD002915-BIB40|cit40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000052143","article-title":"Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine","volume":"45","author":"Pascual","year":"2001","journal-title":"European Neurology"},{"issue":"8","key":"10.1002\/14651858.CD002915-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1212\/WNL.45.8.1505","article-title":"Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan","volume":"45","author":"Rapoport","year":"1995","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD002915-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archneur.1996.00550110072014","article-title":"Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study","volume":"53","author":"Visser","year":"1996","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD002915-BIB43|cit43","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/S0022-510X(97)85694-8","article-title":"Adolescent migraine: efficacy and safety of sumatriptan tablets [Abstract]","volume":"150 Suppl 1","author":"Winner","year":"1997","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"10.1002\/14651858.CD002915-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0149-2918(00)80083-1","article-title":"Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials","volume":"22","author":"Cady","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD002915-BIB45|cit45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1185\/0300799009117025","article-title":"Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study","volume":"16","author":"Dowson","year":"2000","journal-title":"Current Medical Research & Opinion"},{"key":"10.1002\/14651858.CD002915-BIB46|cit46","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/S0022-510X(97)85678-X","article-title":"Assessment of response consistency to oral sumatriptan in migraine attacks [Abstract]","volume":"150 Suppl 1","author":"D\u00edez-Tejedor","year":"1997","journal-title":"Journal of the Neurological Sciences"},{"issue":"2","key":"10.1002\/14651858.CD002915-BIB47|cit47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1526-4610.2000.00017.x","article-title":"A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine","volume":"40","author":"Gallagher","year":"2000","journal-title":"Headache"},{"issue":"8770","key":"10.1002\/14651858.CD002915-BIB48|cit48","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0140-6736(91)90666-D","article-title":"Oral sumatriptan in acute migraine","volume":"338","author":"Goadsby","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD002915-BIB49|cit49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1468-1331.2001.00218.x","article-title":"Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study","volume":"8","author":"Gruffyd-Jones","year":"2001","journal-title":"European Journal of Neurology"},{"issue":"10","key":"10.1002\/14651858.CD002915-BIB50|cit50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1046\/j.1526-4610.2000.00144.x","article-title":"Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study","volume":"40","author":"Cady","year":"2000","journal-title":"Headache"},{"issue":"10","key":"10.1002\/14651858.CD002915-BIB51|cit51","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1526-4610.2000.00143.x","article-title":"Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study","volume":"40","author":"Lipton","year":"2000","journal-title":"Headache"},{"issue":"29","key":"10.1002\/14651858.CD002915-BIB52|cit52","first-page":"3430","article-title":"Sumatriptan in the treatment of migraine in general practice patients","volume":"114","author":"Midelfart","year":"1994","journal-title":"Tidsskrift for Den Norske Laegeforening"},{"issue":"2","key":"10.1002\/14651858.CD002915-BIB53|cit53","first-page":"105","article-title":"Efficacy and tolerability of oral sumatriptan in Indian patients with acute migraine; a multicentre study","volume":"46","author":"Padma","year":"1998","journal-title":"Neurology India"},{"issue":"2","key":"10.1002\/14651858.CD002915-BIB54|cit54","first-page":"57","article-title":"Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine","volume":"19","author":"Pini","year":"1999","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"8 Suppl 7","key":"10.1002\/14651858.CD002915-BIB55|cit55","first-page":"S15","article-title":"Oral sumatriptan for the long-term treatment of migraine: clinical findings","volume":"45","author":"Rederich","year":"1995","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD002915-BIB56|cit56","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00043764-200206000-00013","article-title":"The economic burden of lost productivity due to migraine headache: a specific worksite analysis","volume":"44","author":"Burton","year":"2002","journal-title":"Journal of Occupational & Environmental Medicine"},{"issue":"6","key":"10.1002\/14651858.CD002915-BIB57|cit57","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1468-2982.2000.00082.x","article-title":"Determinants of patient satisfaction with migraine therapy","volume":"20","author":"Davies","year":"2000","journal-title":"Cephalalgia"},{"issue":"6964","key":"10.1002\/14651858.CD002915-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD002915-BIB59|cit59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1526-4610.2002.04262.x","article-title":"The economic impact of migraine: an analysis of direct and indirect costs","volume":"42","author":"Edmeads","year":"2002","journal-title":"Headache"},{"issue":"9294","key":"10.1002\/14651858.CD002915-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","article-title":"Oral triptans (serotonin 5-HT1B\/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials","volume":"358","author":"Ferrari","year":"2001","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD002915-BIB61|cit61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1468-2982.2002.00404.x","article-title":"Triptans (serotonin, 5-HT1B\/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials","volume":"22","author":"Ferrari","year":"2002","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1002\/14651858.CD002915-BIB62|cit62","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0149-2918(01)80006-0","article-title":"Effect of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine","volume":"23","author":"Fuseau","year":"2001","journal-title":"Clinical Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD002915-BIB63|cit63","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.159.8.813","article-title":"Burden of migraine in the United States: disability and economic costs","volume":"159","author":"Hu","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002915-BIB64|cit64","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8 Suppl 7","year":"1988","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD002915-BIB65|cit65","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1468-2982.2000.00117.x","article-title":"Guidelines for controlled trials of drugs in migraine: second edition","volume":"20","author":"Tfelt-Hansen","year":"2000","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD002915-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD002915-BIB67|cit67","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1526-4610.1999.00006.x","article-title":"Acute migraine therapy: do doctors understand what patients with migraine want from therapy?","volume":"39 Suppl 2","author":"Lipton","year":"1999","journal-title":"Headache"},{"issue":"7","key":"10.1002\/14651858.CD002915-BIB68|cit68","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: data from the American Migraine Study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD002915-BIB69|cit69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00019053-199202010-00008","article-title":"Healthcare resource and lost labour costs of migraine headache in the US","volume":"2","author":"Osterhaus","year":"1992","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1002\/14651858.CD002915-BIB70|cit70","first-page":"11","article-title":"Mechanisms of migraine headache: the human evidence","volume":"14","author":"Spierings","year":"2003","journal-title":"Headache & Pain (formerly Headache Quarterly)"},{"issue":"6 Suppl 4","key":"10.1002\/14651858.CD002915-BIB71|cit71","first-page":"S17","article-title":"Migraine prevalence. A review of population-based studies","volume":"44","author":"Stewart","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002915.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000},"record-id":"33396"},{"DOI":"10.1002\/14651858.cd002915.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:13:52Z","timestamp":1628543632000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002915"}},"subtitle":[],"editor":[{"given":"Douglas C","family":"McCrory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,7,21]]},"references-count":71,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002915","relation":{"withdrawal":[{"id-type":"doi","id":"10.1002\/14651858.CD002915.pub2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2003,7,21]]}}}